NCT05542940View on ClinicalTrials.gov

P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Endometrial Cancer
Interventions
OTHER

p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading

p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading

Trial Locations (1)

Unknown

Hossam Hassan El Sokkary, Alexandria

All Listed Sponsors
lead

Hossam Hassan Aly Hassan El Sokkary

OTHER

NCT05542940 - P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer | Biotech Hunter | Biotech Hunter